Relative bioavailability of two different formulations of nerandomilast and investigation of the food effect on new formulation following oral administration in healthy adult male and female subjects (an open-label, randomised, single-dose, three-way crossover trial)

This study is designed to understand how a new medicine, nerandomilast, works in your body. We are specifically looking at two different ways this medicine is made, or 'formulations'. Think of it like comparing two slightly different recipes for the same cake – we want to see if they end up being absorbed by the body in the same way.

One important part of the study is to see if taking the new version of the medicine with food changes how your body takes it in. For some medicines, food can make a big difference, either helping it work better or making it less effective. By finding this out, we can give clear advice to future patients about whether to take the medicine with or without a meal.

This kind of study is called a 'Phase 1' study. It's usually the first time a new medicine is given to people, but in this case, it's focused on healthy volunteers. The goal is to gather basic information about how the medicine behaves in the body rather than to treat a specific illness. The results will help doctors and scientists decide the best way to give nerandomilast to patients in future studies.